Elanco Animal Health (ELAN) Assets Average (2018 - 2026)
Elanco Animal Health (ELAN) posted Assets Average of $13.3 billion for Q1 2026, down 1.22% sequentially from $13.5 billion in Q4 2025, and up 4.01% YoY from $12.8 billion in Q1 2025.
Elanco Animal Health (ELAN) Assets Average (2018 - 2026) Analysis & Trends
Elanco Animal Health has reported Assets Average for 9 years, with the latest figure at $13.3 billion in Q1 2026.
- Quarterly Assets Average rose 4.01% year-over-year to $13.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 billion (up 4.01% YoY) and the FY2025 annual result came in at $13.0 billion, down 3.72% from the prior year.
- Assets Average fell to $13.3 billion in Q1 2026 per ELAN's latest filing, from $13.5 billion in the prior quarter.
- Over five years, Assets Average peaked at $16.4 billion in Q1 2022 and troughed at $12.8 billion in Q1 2025.
- A 5-year average of $14.4 billion and a median of $14.2 billion in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2026: Assets Average decreased 11.98% in 2024, then climbed 4.01% in 2026.
- Over 5 years, Assets Average stood at $15.2 billion in 2022, then fell by 5.69% to $14.4 billion in 2023, then fell by 9.79% to $12.9 billion in 2024, then grew by 3.91% to $13.5 billion in 2025, then slipped by 1.22% to $13.3 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $13.3 billion, $13.5 billion, and $13.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 4.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.39 Bn |
| Mar 31, 2026 | 13.29 Bn |
| Dec 31, 2025 | 13.45 Bn |
| Sep 30, 2025 | 13.65 Bn |
| Jun 30, 2025 | 13.34 Bn |
| Mar 31, 2025 | 12.78 Bn |
| Dec 31, 2024 | 12.95 Bn |
| Sep 30, 2024 | 13.52 Bn |
| Jun 30, 2024 | 13.89 Bn |
| Mar 31, 2024 | 14.19 Bn |
| Dec 31, 2023 | 14.35 Bn |
| Sep 30, 2023 | 15.07 Bn |
| Jun 30, 2023 | 15.78 Bn |
| Mar 31, 2023 | 15.63 Bn |
| Dec 31, 2022 | 15.22 Bn |
| Sep 30, 2022 | 15.27 Bn |
| Jun 30, 2022 | 15.93 Bn |
| Mar 31, 2022 | 16.36 Bn |
| Dec 31, 2021 | 16.52 Bn |
| Sep 30, 2021 | 16.70 Bn |